| EXR |
Report |
Core FFO per share (Q2 2026) |
BEAT |
pred ~$2.09 vs. cons $2.06 |
MEDIUM |
| EXR |
Report |
Same-store revenue growth (Q2 2026, YoY) |
BEAT |
pred ~2.2% vs. cons 1.9% |
MEDIUM |
| EXR |
Report |
Same-store NOI growth (Q2 2026, YoY) |
BEAT |
pred ~2.2% vs. cons 1.8% |
MEDIUM |
| EXR |
Guide |
FY2026 Core FFO guidance (raise/narrow) |
BETTER |
guide ~$8.28 midpoint vs. cons $8.25 (FY2026) |
MEDIUM |
| EXR |
Guide |
FY2026 same-store revenue growth guidance |
BETTER |
guide ~1.1% midpoint vs. cons 1.0% (FY2026) |
MEDIUM |
| EXR |
Guide |
FY2026 same-store NOI growth guidance |
BETTER |
guide ~1.0% midpoint vs. cons 0.5% (FY2026) |
MEDIUM |
| EXR |
Guide |
FY2026 acquisitions volume guidance |
UNCHANGED |
guide ~$200M vs. cons $200M (FY2026) |
MEDIUM |
| EXR |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.0% |
— |
MEDIUM |
| EXR |
Return |
5-day cumulative residual |
+0.8% (FADE) |
Stock already re-rated ~15% off March lows on Nareit checks/BofA upgrade and now trades near NAV (17.8x vs ~19.5x historical FFO multiple), so a modest FFO beat plus an expected-but-already-priced-in guidance raise likely triggers an initial pop that partially fades as some investors take profits into strength; unless the raise is materially larger than the flagged low-single-digit narrowing, out-year FFO/NOI revisions are unlikely to expand enough over the week to sustain the full day-1 move, especially in a market with rising REIT-sector volatility around 10-yr yields. |
MEDIUM |